An analysis of data from more than 3k women followed for up to 20 years indicates increased frequency of vasomotor menopausal symptoms was associated with a 52% greater risk of incident cardiovascular disease.
The US FDA has approved vericiguat (Verquvo) for reducing the risk of cardiovascular death and heart failure hospitalization following a hospitalization for heart failure or need for outpatient intravenous diuretics in patients with HFrEF.
While social media and technology have allowed greater sharing of ideas and knowledge, they have also become a major source of misinformation. In this column, Dr. Weiss reflects on practicing during the age of misinformation.
Results from a systematic review and meta-analysis of more than 50 studies assessing cardiovascular risk with levels of abdominal aortic calcification indicate increased AAC was linked to 80% increase in risk of cardiovascular events and cardiovascular death.
A quality improvement study conducted at a trio of Penn Medicine hospitals suggests changing cardiac rehabilitation referrals from an opt-in to an opt-out decision in their EHR could drastically improve referral rates.
An analysis of more than 100k people from five community-based cohorts indicates consuming one alcoholic drink per day could increase risk of atrial fibrillation by 16%, while consuming four per day increased risk by 47%.